PNC Financial Services Group
TXMD icon

PNC Financial Services Group’s TherapeuticsMD TXMD Stock Holding History

PNC Financial Services Group’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12
Closed -$49 – 4762
2023
Q2 		$49 Buy
+12
New +$47 ﹤0.01% 4708
2023
Q1 		– Sell
-4
Closed -$22 – 4821
2022
Q4 		$22 Buy
+4
New +$24 ﹤0.01% 4741
2021
Q3 		– Sell
-44
Closed -$3K – 4410
2021
Q2 		$3K Sell
44
-43
-49% -$2.6K ﹤0.01% 3991
2021
Q1 		$6K Buy
87
+40
+85% +$3.13K ﹤0.01% 3788
2020
Q4 		$3K Hold
47
– – ﹤0.01% 3803
2020
Q3 		$3K Hold
47
– – ﹤0.01% 3774
2020
Q2 		$3K Hold
47
– – ﹤0.01% 3733
2020
Q1 		$2K Hold
47
– – ﹤0.01% 3756
2019
Q4 		$5K Hold
47
– – ﹤0.01% 3670
2019
Q3 		$8K Sell
47
-42
-47% -$5.92K ﹤0.01% 3642
2019
Q2 		$11K Buy
89
+36
+68% +$6.45K ﹤0.01% 3541
2019
Q1 		$12K Hold
53
– – ﹤0.01% 3551
2018
Q4 		$9K Buy
53
+10
+23% +$2.44K ﹤0.01% 3584
2018
Q3 		$15K Hold
43
– – ﹤0.01% 3542
2018
Q2 		$14K Hold
43
– – ﹤0.01% 3578
2018
Q1 		$10K Hold
43
– – ﹤0.01% 3717
2017
Q4 		$12K Buy
43
+37
+617% +$10.3K ﹤0.01% 3632
2017
Q3 		$2K Hold
6
– – ﹤0.01% 4031
2017
Q2 		$2K Hold
6
– – ﹤0.01% 4017
2017
Q1 		$2K Sell
6
-2
-25% -$619 ﹤0.01% 3967
2016
Q4 		$2K Sell
8
-40
-83% -$12.4K ﹤0.01% 3862
2016
Q3 		$16K Sell
48
-6
-11% -$2.19K ﹤0.01% 3326
2016
Q2 		$23K Buy
54
+20
+59% +$8.24K ﹤0.01% 3199
2016
Q1 		$11K Buy
34
+3
+10% +$1.02K ﹤0.01% 3546
2015
Q4 		$16K Hold
31
– – ﹤0.01% 3412
2015
Q3 		$9K Buy
31
+20
+182% +$7.11K ﹤0.01% 3726
2015
Q2 		$4K Buy
11
+5
+83% +$1.76K ﹤0.01% 4189
2015
Q1 		$2K Hold
6
– – ﹤0.01% 4327
2014
Q4 		$1K Hold
6
– – ﹤0.01% 4022
2014
Q3 		$1K Hold
6
– – ﹤0.01% 3863
2014
Q2 		$1K Hold
6
– – ﹤0.01% 3708
2014
Q1 		$2K Buy
+6
New +$1.91K ﹤0.01% 3520

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's TXMD Position: Q3 2023 in Review

PNC Financial Services Group sold out of TherapeuticsMD (TXMD) in Q3 2023, closing a stake of 12 shares — an estimated $49 sold.

PNC Financial Services Group first reported a position in TXMD in Q1 2014 and held it in 32 quarters. The position peaked at $23K in Q2 2016. 36 funds tracked by Wall St. Rank hold TXMD as of Q3 2023.

  • PNC Financial Services Group reported no remaining TherapeuticsMD position as of Q3 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 12 TherapeuticsMD shares in Q3 2023, an estimated $49.
  • PNC Financial Services Group first reported a position in TherapeuticsMD in Q1 2014 and held it in 32 quarters.
  • PNC Financial Services Group's TherapeuticsMD position peaked at $23K in Q2 2016.
  • 36 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2023.

Based on PNC Financial Services Group's 13F filing for Q3 2023, filed 13 Nov 2023.